PI
VRCA icon

PFG Investments’s Verrica Pharmaceuticals VRCA Stock Holding History

PFG Investments’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,784
Closed -$19.5K – 1104
2024
Q4 		$19.5K Buy
+2,784
New +$30.6K ﹤0.01% 1009

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return

PFG Investments's VRCA Position: Q1 2025 in Review

PFG Investments sold out of Verrica Pharmaceuticals (VRCA) in Q1 2025, closing a stake of 2,784 shares — an estimated $19.5K sold.

PFG Investments first reported a position in VRCA in Q4 2024 and held it in 1 quarter. The position peaked at $19.5K in Q4 2024. 74 funds tracked by Wall St. Rank hold VRCA as of Q1 2025.

  • PFG Investments reported no remaining Verrica Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • PFG Investments sold 2,784 Verrica Pharmaceuticals shares in Q1 2025, an estimated $19.5K.
  • PFG Investments first reported a position in Verrica Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • PFG Investments's Verrica Pharmaceuticals position peaked at $19.5K in Q4 2024.
  • 74 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2025.

Based on PFG Investments's 13F filing for Q1 2025, filed 22 Apr 2025.